SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-024996
Filing Date
2024-05-23
Accepted
2024-05-23 16:58:53
Documents
14
Period of Report
2024-05-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20240522.htm   iXBRL 8-K 24386
5 ardx-20240522_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-24-024996.txt   157371

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20240522.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20240522_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20240522_pre.xml EX-101.PRE 13046
17 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20240522_htm.xml XML 2892
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 24979344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)